Table 3.
Relationship of ATP concentration with TEQ or plasma levels of individual POPs (ln-TEQ, ln-POPs, pg/mL) are represented by regression coefficients (β) with corresponding 95% CIs and P values in linear regression models adjusted for sex, serum cholesterol, and serum triglycerides (n = 911).
| Variable | β coefficient (95% CI) | P value |
|---|---|---|
| TEQtotal | −1.84 (−2.71, −0.97) | 0.000040* |
| TEQplanar | −1.80 (−2.65, −0.94) | 0.000042* |
| TEQortho | −1.15 (−2.67, 0.37) | 0.14 |
| PCB74 | −0.53 (−1.64, 0.59) | 0.36 |
| PCB 99 | −0.055 (−1.035, .093) | 0.91 |
| PCB138 | −.0167 (−1.44, 1.10) | 0.80 |
| PCB153 | −0.73 (−2.14, 0.68) | 0.31 |
| PCB170 | −1.15 (−2.74, 0.45) | 0.16 |
| PCB180 | −0.98 (−2.55, 0.59) | 0.22 |
| PCB194 | −0.27 (−0.99, 0.46) | 0.47 |
| PCB206 | −1.51 (−2.97, −0.055) | 0.042* |
| PCB209 | −1.99 (−3.28, −0.70) | 0.0025* |
| PCB105 | −.023 (−1.18, 0.72) | 0.63 |
| PCB118 | −0.33 (−1.40, 0.74) | 0.55 |
| PCB156 | −0.98 (−2.41, 0.45) | 0.18 |
| PCB157 | −0.71 (−2.05, 0.63) | 0.30 |
| PCB189 | −0.66 (−1.51, 0.20) | 0.13 |
| PCB126 | −1.22 (−1.84, −0.61) | 0.00011* |
| PCB169 | −1.857 (−3.08, −0.63) | 0.0030* |
| OCDD | −0.48 (−1.41, 0.45) | 0.31 |
| BDE47 | 0.099 (−0.72, 0.92) | 0.81 |
*Indicates significant P value. All variables were natural log-transformed.
CI, confidence interval; TEQ, toxic equivalence; PCB, polychlorinated biphenyl; TEQplanar: TEQ for dioxin-like coplanar, non-ortho-substituted PCBs; TEQortho: TEQ for dioxin-like mono-ortho-substituted PCBs; OCDD, octachlorinated dibenzo-p-dioxin; BDE, brominated diphenyl ether.